Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Trial for High-risk Asymptomatic or Minimally Symptomatic Bone Metastases: Early Radiotherapy Versus Observation

NCT07146074 is registered in ClinicalTrials.gov with Cancer Research Antwerp as lead sponsor.

NCT NCT07146074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07146074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Trial for High-risk Asymptomatic or Minimally Symptomatic Bone Metastases: Early Radiotherapy Versus Observation
Lead sponsor
Cancer Research Antwerp
Phase
Not applicable
Overall status
Recruiting
Start date
February 5, 2025
Completion date
February 28, 2029
Enrollment
120 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

asymptomatic or minimally symptomatic, bone metastases, high risk for skeletal events, solid neoplasms